Home Neuronal Signaling Adrenergic Receptor antagonist Betaxolol HCl For research use only.

Betaxolol HCl

Synonyms: SL 75212 HCl

Betaxolol (SL 75212) is a β1 adrenergic receptor blocker with IC50 of 6 μM.

Betaxolol HCl Chemical Structure

Betaxolol HCl Chemical Structure

CAS: 63659-19-8

Selleck's Betaxolol HCl has been cited by 1 publication

Purity & Quality Control

Batch: Purity: 99.46%
99.46

Betaxolol HCl Related Products

Signaling Pathway

Adrenergic Receptor Signaling Pathways

Adrenergic Receptor Signaling Pathway

Choose Selective Adrenergic Receptor Inhibitors

Biological Activity

Description Betaxolol (SL 75212) is a β1 adrenergic receptor blocker with IC50 of 6 μM.
Targets
β1-adrenergic receptor [1]
6 μM
In vitro
In vitro Betaxolol is able to protect retinal neurones. [2] Betaxolol attenuates the NMDA-induced influx of 45Ca2+ while β-adrenoreceptor agonists are ineffective. [3] The glutamate-induced release of LDH is almost completely prevented when betaxolol (10 μM) is included. [4] Betaxolol (100 μM) is very effective in preventing the hypoxia-induced release of LDH from cortical cultures. [5]
Cell Research Cell lines Dissociated rat cortical cells
Concentrations 100 μM
Incubation Time 4 hours
Method Dissociated cortical cells from 16–18-day-old fetal rats are grown, in 35 mm dishes, in DMEM supplemented with L-glutamine (4 mM), glucose (6 g/L), penicillin (100 U/mL), streptomycin (100 μg/mL) and 10% hormonal supplemented medium consisting of transferrin (1 mg/mL), insulin (250 μg/mL) putrescine (600 μM), sodium selenite (0.3 μM), progesterone (0.2 μM) and estradiol (0.1 pM) for 7 days in an atmosphere of 5% CO2/95% O2 at 37 °C. The cultures are then transferred to a culture medium which lacks the hormonal supplemented medium. L-glutamate is added to the medium and incubated for a further 4 hours under normoxic conditions. Betaxolol are added to the cultures at the same time as L-glutamate. In other experiments the cultures are subjected to anoxic conditions, 95% N2/5% CO2, for 5 hours at 37 °C. Betaxolol is added prior to anoxia. Reoxygenation is then achieved by replacing the cells in normoxic conditions (95% O2/5% CO2) for 3 hours. Cellular injury is assessed by measuring lactate dehydrogenase (LDH) release into the cell culture supernatant after hypoxia/reoxygenation or glutamate exposure. LDH activity is assayed spectrophotometrically by following NADH metabolism for 2 minutes at 340 nm.
In Vivo
In vivo When Betaxolol is injected i.p. into the rats before ischaemia and on the days of reperfusion the changes to the calretinin and ChAT immunoreactivities are reduced and the reduction of the b-wave is prevented. Inclusion of betaxolol partially prevents the changes caused by NMDA and lack of oxygen/glucose. [5]
Animal Research Animal Models Rat wiht ischaemia
Dosages 2.5 mg/kg
Administration Administered via i.p.

Chemical Information & Solubility

Molecular Weight 343.89 Formula

C18H29NO3.HCl
CAS No. 63659-19-8 SDF Download Betaxolol HCl SDF
Smiles CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 69 mg/mL ( (200.64 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 69 mg/mL

Ethanol : 69 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Betaxolol HCl | Betaxolol HCl ic50 | Betaxolol HCl price | Betaxolol HCl cost | Betaxolol HCl solubility dmso | Betaxolol HCl purchase | Betaxolol HCl manufacturer | Betaxolol HCl research buy | Betaxolol HCl order | Betaxolol HCl mouse | Betaxolol HCl chemical structure | Betaxolol HCl mw | Betaxolol HCl molecular weight | Betaxolol HCl datasheet | Betaxolol HCl supplier | Betaxolol HCl in vitro | Betaxolol HCl cell line | Betaxolol HCl concentration | Betaxolol HCl nmr